Tourmaline Bio Company Leadership
| TRML Stock | 19.77 1.02 5.44% |
Tourmaline Bio employs about 74 people. The company is managed by 15 executives with a total tenure of roughly 173 years, averaging almost 11.0 years of service per executive, having 4.93 employees per reported executive. Inspection of Tourmaline Bio's management performance can provide insight into the company performance.
Tourmaline | Build AI portfolio with Tourmaline Stock |
Tourmaline Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.1903) % which means that it has lost $0.1903 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2614) %, meaning that it created substantial loss on money invested by shareholders. Tourmaline Bio's management efficiency ratios could be used to measure how well Tourmaline Bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.25. The value of Return On Capital Employed is expected to slide to -0.31. At this time, Tourmaline Bio's Total Assets are quite stable compared to the past year. Non Current Assets Total is expected to rise to about 42.2 M this year, although the value of Debt To Assets will most likely fall to 0.0008.Common Stock Shares Outstanding is expected to rise to about 26.6 M this year
Tourmaline Bio Workforce Comparison
Tourmaline Bio is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 162,949. Tourmaline Bio adds roughly 74.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Tourmaline Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tourmaline Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tourmaline Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Tourmaline Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tourmaline Bio Notable Stakeholders
A Tourmaline Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tourmaline Bio often face trade-offs trying to please all of them. Tourmaline Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tourmaline Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Sandeep MD | CEO CoFounder | Profile | |
| John MD | VP Affairs | Profile | |
| Famina PharmD | VP Pharmacovigilance | Profile | |
| Susan Jones | Chief Officer | Profile | |
| Kimberly Piorkowski | Culture People | Profile | |
| Bradford JD | General Officer | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Emil MD | Senior Research | Profile | |
| Yung MD | Chief Officer | Profile | |
| Gerhard PharmD | Senior Development | Profile | |
| Kristine OD | Medical Ophthalmology | Profile | |
| Dora Rau | Senior Quality | Profile | |
| Ryan Iarrobino | Senior Development | Profile | |
| Don Fitch | Senior Development | Profile | |
| Ryan CPA | Controller Finance | Profile |
About Tourmaline Bio Management Performance
The success or failure of an entity such as Tourmaline Bio often depends on how effective the management is. Tourmaline Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tourmaline management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tourmaline management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.24) | (0.25) | |
| Return On Capital Employed | (0.30) | (0.31) | |
| Return On Assets | (0.24) | (0.25) | |
| Return On Equity | (0.24) | (0.23) |
Tourmaline Bio Workforce Analysis
Traditionally, organizations such as Tourmaline Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tourmaline Bio within its industry.Tourmaline Bio Manpower Efficiency
Return on Tourmaline Bio Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 989.3K | |
| Net Loss Per Executive | 4.9M | |
| Working Capital Per Employee | 3.5M | |
| Working Capital Per Executive | 17.3M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.